Opportunity Overview
T cell receptors (TCRs). Antigen-TCR binding initiates signalling cascades to promote effector functions including cytokine release,
proliferation and cytotoxicity. Insights into T cell signalling are key to optimising T cell-based therapies in cancer. Despite its
importance, how antigen-TCR binding initiates signalling inside the cell is an important unresolved question.
Recent structural studies suggest the TCR is rigid and signals without conformational changes, a common cell surface receptor
activation paradigm. Prevailing models in the field draw on the role of receptor tyrosine phosphatases, such as CD45, and TCR
mechanosensing properties. Neither fully explains TCR triggering. The immune system exploits reactive oxygen species such as
hydrogen peroxide for pathogen killing and as a signalling second messenger - a chemical that modifies proteins and changes their
function. Our preliminary data reveals an important new function for hydrogen peroxide in regulating phosphatase-protein
interactions. Here, I propose two new concepts in TCR signalling: 1. Antigen-TCR binding mediates the mechanoregulation of second
messenger hydrogen peroxide; and 2. Control of target protein phosphorylation and localisation by phosphatases is redox-regulated.
My team will use three new mouse models developed in my lab to investigate these concepts. The first enables high-resolution
imaging of hydrogen peroxide spatiotemporal dynamics in primary T cells. The second will facilitate identification of CD45 proximal
proteins in primary cells. Finally, a CD45 mutant with impaired redox sensing will allow us to assess its impact on T cell effector
functions in vivo. This work will not only deliver fundamental insights into T cell signalling, but also has transformative potential for
broader areas of cell-cell communication, and optimisation of T cell...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Horizon Europe Guarantee |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | March 01, 2024 |
| Procurement stage | Active solicitation |
| Closed | Closing date not published |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 10, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Browse Similar Open Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.